Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues-Reference-Cited by-同舟云学术

Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues

Published:2020-08-03 Issue:16 Volume:59 Page:11676-11687
ISSN:0020-1669
Container-title:Inorganic Chemistry
language:en
Short-container-title:Inorg. Chem.

Author:

Chen Shu¹²,Yao Houzong¹²,Zhou Qiyuan¹²,Tse Man-Kit¹,Gunawan Yuliana F.¹,Zhu Guangyu¹²^ORCID

Affiliation:

1. Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong SAR 999077, People’s Republic of China

2. City University of Hong Kong, Shenzhen Research Institute, Shenzhen 5108057, People’s Republic of China

Funder

Research Grants Council, University Grants Committee

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Inorganic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.inorgchem.0c01541

Reference36 articles.

1. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

2. The resurgence of platinum-based cancer chemotherapy

3. The status of platinum anticancer drugs in the clinic and in clinical trials

4. Mechanisms of Cisplatin Nephrotoxicity

5. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-12

2. Recent updates in nanoscale delivery systems of platinum(IV) antitumor prodrugs;Coordination Chemistry Reviews;2024-06

3. Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance;Journal of Medicinal Chemistry;2024-05-10

4. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions;Journal of Medicinal Chemistry;2024-04-09

5. Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance;Journal of Medicinal Chemistry;2024-04-04